Subject: NIH GUIDE - Vol. 19, No. 33, September 14, 1990
From: Dot Baker <[email-masked]>
To: [email-masked]
Date: Thu, 13 Sep 90 08:56 EST

good morning paul,
this the latest nih guide. please post to the nih list server as follows
     nihguide.091490
                    thanks dottie
 ---------------------------- Text of forwarded message -----------------------
 
X-comment: NIH Guide (including TOC) contained 7 pages (560 lines)
No RFAs present

 

 
NIH GUIDE - Vol. 19, No. 33, September 14, 1990

                                   NOTICES

NIDDK CENTER DIRECTORS MEETING ..........................(84/103)............ 1
National Institute of Diabetes and Digestive and Kidney Diseases
Index:  DIABETES, DIGESTIVE DISEASES, KIDNEY DISEASES

INTERIM GUIDANCE ON THE BYRD ANTI-LOBBYING PROVISION (PUBLIC LAW
101-121) ................................................(106/207)........... 1
National Institutes of Health
Index:  NATIONAL INSTITUTES OF HEALTH

                   NOTICES OF AVAILABILITY (RFPs AND RFAs)

SCHOOL-AGE FOLLOW-UP OF EXTRA CORPOREAL MEMBRANE OXYGENATION (RFI) .......... 2
National Institute of Neurological Disorders and Stroke  (213/271)
Index:  NEUROLOGICAL DISORDERS, STROKE

NEUROPSYCHOLOGICAL TESTING FOR CHILDREN AND ADULTS WITH HIV DISEASE (RFP) ... 3
National Cancer Institute                                (274/317)
Index:  CANCER

REPOSITORY OF HUMAN DNA PROBES AND LIBRARIES (RFP) ......(321/371)........... 4
National Institute of Child Health and Human Development
Index:  CHILD HEALTH, HUMAN DEVELOPMENT

MINORITY RESEARCH FELLOWSHIP IN PSYCHOLOGY
MINORITY RESEARCH FELLOWSHIP IN MENTAL HEALTH NURSING (RFA MH-90-21) ........ 4
National Institute of Mental Health                      (374/416)
Index:  MENTAL HEALTH

                        ONGOING PROGRAM ANNOUNCEMENTS

PREVENTIVE CARDIOLOGY ACADEMIC AWARD (PA-90-33) .........(422/519)........... 5
National Heart, Lung, and Blood Institute
Index:  HEART, LUNG, BLOOD

 

 

 

 

 

 

 

 

 
                                   NOTICES

NIDDK CENTER DIRECTORS MEETING
 
P.T. O4, 42; K.W. 1014006
 
National Institute of Diabetes and Digestive and Kidney Diseases
 
A meeting of Center Directors supported by the National Institute of Diabetes
and Digestive and Kidney Diseases is scheduled for October 15 and 16, 1990, at
the NIH campus in Bethesda, Maryland.  The purpose of the meeting is to inform
investigators of current institute policies and guidelines concerning research
centers.  The meeting is open on a space-available basis.
 
For further information contact:
 
Dr. Ralph L. Bain
Program Director
Kidney and Urologic Diseases Research Centers Program
National Institute of Diabetes and Digestive and Kidney Diseases
Federal Building, Room 102
Bethesda, MD  20892

INTERIM GUIDANCE ON THE BYRD ANTI-LOBBYING PROVISION (PUBLIC LAW 101-121)
 
P.T. 34; K.W. 1014006
 
National Institutes of Health
 
The purpose of this notice is to update information on this subject previously
published in the NIH GUIDE FOR GRANTS AND CONTRACTS.
 
BACKGROUND
 
On October 23, 1989, the President signed into law the Department of Interior
and Related Agencies Appropriations Act for Fiscal Year 1990.  Section 319 of
the Act amends Title 31, U.S.C., by adding a new Section 1352, entitled
Limitation on Use of Appropriated Funds to Influence Certain Federal
Contracting and Financial Transactions (Byrd Anti-Lobbying Provision).
Section 1352 prohibits all Federal contractors and subcontractors from using
appropriated funds to influence or attempt to influence Congress or a Federal
agency in connection with the award of a contract, grant, loan, or cooperative
agreement.  It also requires disclosure of such activities undertaken with
nonappropriated funds, for contracts over $100,000.  The statutory effective
date of Section 319 of the Act was December 23, 1989.
 
Federal Acquisition Circular (FAC) 84-55 implemented the law into the Federal
Acquisition Regulation (FAR) and added both a Provision (FAR 52.203-11) and a
Clause (FAR 52.203-12), to be used in all solicitations and contracts
exceeding $100,000 and in all out-of-scope modifications exceeding $100,000,
as well as a disclosure form, Standard Form LLL, to be submitted by the
offeror/contractor as required.  On March 23, 1990 and June 12, 1990, the
Office of Management and Budget issued clarifications to the lobbying
restrictions, which were then further clarified by the Civilian Agency
Acquisition Council (CAAC).  The substance of these clarifications is provided
below.
 
SUMMARY OF CLARIFICATIONS
 
1.  The certification and disclosure statement apply only to the instant
contract action for which they are being obtained, and not to all Federal
transactions.
 
2.  Only bids, offers, and awards submitted or made on or after the December
23, 1989 effective date and that exceed $100,000, are required to contain
certifications and, if required, disclosures.  Awards made before December 23,
1989, but modified, extended, or renewed after that date do not need
certifications or disclosure statements, unless they are modified beyond the
scope of the award.  If a bilateral modification to an existing contract
requires a Justification for Other than Full and Open Competition (JOFOC) and
exceeds the $100,000 threshold, the certification and disclosure statement (if
applicable) are required.  For JOFOCs where no additional funds are required,
but only additional effort, the certification and disclosure requirements do
not apply.  The requirements of the law also do not apply to contract
modifications that involve incremental funding actions, exercise of options,
or cost overruns.
 
           NIH GUIDE - Vol. 19, No. 33, September 14, 1990 - Page 1
3.  Selling activities by independent sales representatives that occur before
issuance of any formal solicitation are not considered to be "influencing"
with regard to a particular contract and are, therefore, exempt from the Act.
Examples of such selling activities include:  (a) discussions with an agency
(including individual demonstrations) regarding the qualities and
characteristics of the seller's products or services, conditions or terms of
sales, and service capabilities; and (b) technical discussions and other
activities regarding the application or adaptation of the person's products or
services for an agency's use.
 
4.  For any subcontract exceeding $100,000, a certification and a disclosure
form, if required, shall be filed with the next tier above.  All disclosure
forms shall be forwarded from tier to tier until received by the prime
contractor, who shall forward them to the contracting officer.
 
5.  To the extent that a person can demonstrate that he/she has sufficient
monies, other than Federal appropriated funds, the Government shall assume
that these monies were the ones spent for any influencing activities.  This
assumption applies whether or not cost or pricing data were required to be
submitted.  Where no cost or pricing data are submitted, (e.g., sealed bidding
or negotiated contracts where there is adequate price competition), it shall
be assumed that monies spent are a reduction from profits otherwise available.
In other words, the influencing activities are permitted, since profits and
fees are not considered appropriated funds under the Act.
 
6.  "Professional and technical services" are defined as advice and analysis
directly applying any professional or technical expertise.  Examples of
professional and technical services that are exempt from the Act were outlined
in the December 1989 guidance and in FAR 3.802(c)(2)(ii).  The examples were
not intended to be all-inclusive or to limit the application of the
professional and technical exemption provided in the law.
 
7.  Requests from state and local governments for information or clarification
about grants are permitted under the Act and are not subject to disclosure.
Communications regarding routine and ongoing post-award activities to
administer grants and contracts do not require disclosure since they fall
under the exemption of "professional and technical services."
 
8.  Nothing in the guidelines requires that a person change his or her
existing accounting practices.
 
9.  The required certification and disclosure are a matter of responsibility,
and failure to submit the certification and disclosure, if applicable, renders
the offeror nonresponsible for award.
 
10.  Questions regarding the above policy may be directed to the Acquisition
Policy and Procedure Branch at (301) 496-6014.

                   NOTICES OF AVAILABILITY (RFPs AND RFAs)

SCHOOL-AGE FOLLOW-UP OF EXTRA CORPOREAL MEMBRANE OXYGENATION
 
REQUEST FOR INFORMATION SYNOPSIS NO.  NIH-NINDS-90-001
 
P.T. 34; K.W. 0414013, 0785110
 
National Institute of Neurological Disorders and Stroke
 
The National Institute of Neurological Disorders and Stroke (NINDS) is
interested in obtaining information to identify potential sources that might
have capabilities to provide both extra corporeal membrane oxygenation (ECMO)
survivor and control subjects for follow-up evaluation.  We are interested in
evaluation of two groups of survivors of neonatal respiratory dysfunction:
those who were treated with ECMO and those who might reasonably have been
considered for ECMO but did not receive it.  An in-depth comparison of these
two groups at school age would be made with regard to psychometric measures
and neurologic examination.  The NINDS is seeking to determine if appropriate
populations exist to support such a study.
 
Specifically, information is requested to assess availability of the following
populations on a yearly basis from 1981 through 1988:
 
  1. The number of neonatal patients treated with ECMO in your
     institution.

 
           NIH GUIDE - Vol. 19, No. 33, September 14, 1990 - Page 2
  2. The number of babies admitted to the neonatal Intensive Care Unit
     who were considered for ECMO, but not treated, and survived.
 
  3. The number of children counted in item (2) who had conditions that
     would have disqualified them from ECMO therapy, (e.g., grade 2 or 3
     intraventricular hemmorhage, severe congenital anomalies).
 
  4. The number of survivors considered for ECMO but not treated with no
     disqualifying conditions, and the number of ECMO survivors whom you
     have continued to follow or for whom you could obtain a follow-up
     visit.
 
Responses to this request are not mandatory and are solicited on a voluntary
basis.  The Government does not intend to award a contract on the basis of
responses nor to pay for the preparation of any information that may be
submitted.  This is not a Request for Proposals.  If responses indicate that
sufficient study populations are available, it is the intent of the NINDS to
issue a solicitation for a follow-up study.  Acknowledgment of receipt of
responses will not be made, nor will respondents be notified of the
Government's evaluation of the information received.
 
Responses should be identified with NIH-NINDS RFI Synopsis No. 90-001, and are
due by October 15, 1990.  Please submit three (3) copies of your response to:
 
Mr. Kirkland L. Davis
Contracting Officer
Contracts Management Branch
National Institute of Neurological Disorders and Stroke, NIH
Federal Building, Room 901
7550 Wisconsin Avenue
Bethesda, MD  20892

NEUROPSYCHOLOGICAL TESTING FOR CHILDREN AND ADULTS WITH HIV DISEASE
 
RFP AVAILABLE:  NCI-CM-17529-41
 
P.T. 34, AA; K.W. 0715008, 0414000, 1002030
 
National Cancer Institute
 
The National Cancer Institute (NCI), Pediatric Branch, Clinical Oncology
Program, Division of Cancer Treatment, seeks a Contractor to perform
Neuropsychological Testing for Children and Adults with Human Immunodeficiency
Virus (HIV) Infection.  This will be accomplished through the use of
Neuropsychological Evaluation Personality Assessment and structured
standardized clinical interviews and observations.  It is anticipated that
each year there will be a total of 100 new pediatric and 25 new adult HIV
patients to be evaluated, in addition to the 120 pediatric and 25 adult
patients currently enrolled.  Each patient will be evaluated four times a
year:  A complete evaluation at baseline, 6, and 12 months:  a partial testing
sequence for the second and fourth quarter evaluations.  The contractor shall
provide comprehensive, state-of-the-art neuropsychiatric evaluations of
pediatric and adult NCI patients with HIV infection.  The nature of the
acquisition requires that the contractor have (or provide evidence they can
establish prior to contract award) the ability to provide, within 24 hours,
the personnel and material to accomplish the prescribed work.  The Contractor
must perform most of the required assessments and other work at the Clinical
Center, National Institutes of Health, Bethesda, Maryland.  It is anticipated
that a cost-reimbursement, incrementally funded type contract will be awarded
as a result of the Request for Proposals (RFP) for a period of 48 months.  The
RFP represents a recompetition of the project with the same title being
performed by the Medical Illness Counseling Center.
 
RFP No. NCI-CM-17529-41 will be issued on approximately September 14, 1990,
and responses will be due November 15, 1990.
 
Copies of the RFP may be obtained by sending a written request to:
 
Mrs. Susan K. Hoffman, Contract Specialist
National Institutes of Health
National Cancer Institute
Research Contracts Branch, TCS
Executive Plaza South, Room 603
9000 Rockville Pike
Bethesda, MD  20892
Telephone:  (301) 496-8620

           NIH GUIDE - Vol. 19, No. 33, September 14, 1990 - Page 3
REPOSITORY OF HUMAN DNA PROBES AND LIBRARIES
 
RFP AVAILABLE:  NICHD-CRMC-90-27
 
P.T. 34; K.W. 0760053, 0780000
 
National Institute of Child Health and Human Development
 
The National Institute of Child Health and Human Development (NICHD) is
seeking an organization to continue maintenance of a repository of human and
mouse DNA probes and human libraries that was established in September 1985 as
a centralized national and international resource providing a reliable and
efficient means for researchers to exchange cloned human DNA.  The repository
is a central storage and processing facility where well characterized human
DNA probes, collected from investigators in the scientific community, can be
expanded, verified and stored in multiple samples for distribution to other
investigators working in the research fields of genetics and human genetic
research.  Quality control is maintained and the probes deposited in this
facility emphasize relevancy to human genetic disease.  Representative
chromosome-specific genes/probes are being acquired to span each individual
chromosome and the probes represent important genes, polymorphisms, disease,
and significant chromosomal locations for genetic linkage analysis.  The NICHD
wants continued support of this facility so that new technologies can be
introduced that will allow characterization of genes identified with human
genetic disease.  An increase of 300 new human cDNAs per year and 200 mouse
cDNAs per year for approximately 2,500 additional new probes will take about 5
years.  The selected contractor will be expected to maintain and distribute
the already existing inventory of 1,099 human and 65 mouse probes and cloned
genes and 65 human libraries.  This centralized resource will facilitate
studies of a wide variety of human genetic diseases.  It will also provide
large overlapping sequences that will be prepared as large inserts in cosmic
vectors that will aid the mapping and sequencing of the entire genome.
Interaction among various government components will be necessary in order to
accomplish this project.
 
This announcement is a recompetition for a repository of Human DNA Probes and
Libraries.  The issuance of this RFP will be on or about September 25, 1990
and proposals are due by 4:00pm (Local Time), December 11, 1990.  Those
organizations desiring a copy of the above RFP may send their written request
to:
 
Mrs. Lynn Salo
NICHD, OGC, CMS
Executive Plaza North Bldg., Rm. 515
9000 Rockville Pike
Bethesda, MD  20892
 
To receive a copy of the RFP, please supply this office with two
self-addressed mailing lables.  All responsible sources may submit a proposal
which will be considered.  This advertisement does not commit the Government
to award a contract.

MINORITY RESEARCH FELLOWSHIP IN PSYCHOLOGY
MINORITY RESEARCH FELLOWSHIP IN MENTAL HEALTH NURSING
 
RFA AVAILABLE:  MH-90-21
 
P.T. 34, FF; K.W. 0720005, 0414000, 0715095, 0785130
 
National Institute of Mental Health
 
Application Receipt Date:  January 10, 1991
 
The National Institute of Mental Health (NIMH) is issuing a dual announcement
of a Minority Research Fellowship Program in Psychology and a Minority
Research Fellowship Program in Nursing.  Its purpose is to encourage
applications designed to support the development and training of individuals
in doctoral programs in psychology and mental health nursing to enable them to
undertake active, productive careers in scientific investigations related to
mental health and mental illness.  The specific purpose of these awards is to
ensure that minority investigators assume a prominent position among the next
generation of the Nation's mental health researchers.
 
A Minority Research Fellowship grant may be made for a period of up to 5
years.  It is anticipated that a single award of up to $350,000, pending
availability of funds, will be granted in each of these disciplines in fiscal
year 1991.  Domestic public or private nonprofit institutions and scientific
 
           NIH GUIDE - Vol. 19, No. 33, September 14, 1990 - Page 4
organizations and associations may apply.  NIMH will accept applications for
these grants under the single receipt date of January 10, 1991.  Selection for
funding will be made after competitive review.  Applicants are encouraged to
contact Institute staff for information before applying for an award.  Staff
consultation on the Minority Research Fellowship Program in Psychology and the
Minority Research Fellowship Program in Mental Health Nursing is available
from:
 
Dr. Marion E. Primas
Acting Assistant Chief
Minority Research Resources Branch
Division of Biometry and Applied Sciences
National Institute of Mental Health
5600 Fishers Lane, Room 18-101
Rockville, MD  20857
Telephone:  (301) 443-3724

                        ONGOING PROGRAM ANNOUNCEMENTS

PREVENTIVE CARDIOLOGY ACADEMIC AWARD
 
PA:  PA-90-33
 
P.T. 34, FF; K.W. 0715040, 0745027, 0785025
 
National Heart, Lung, and Blood Institute
 
Application Receipt Date: December 7, 1990
 
Each year, the Division of Epidemiology and Clinical Applications (DECA) of
the National Heart, Lung, and Blood Institute (NHLBI) invites national
competition for Preventive Cardiology Academic Awards (PCAA).  These awards
have the dual purpose of improving the quality of preventive cardiology
curricula and fostering research and careers in the prevention of heart
disease.
 
Previously, any school of medicine or osteopathy in the United States and its
possessions or territories was eligible to compete for a PCAA.  Although past
awards have been made to a diverse group of medical schools, competition for
this PCAA announcement is limited to medical schools training a large
percentage of underrepresented minorities or minority medical schools.
 
This year, the eligibility criteria for the PCAA program have been modified.
Institutions responding to this announcement should be medical schools
providing physician training to a significant number of underrepresented
minorities or minority medical schools.  Cardiovascular disease is the major
cause of death for minorities in the United States and preventive strategies
afford an important opportunity to improve the health status of minorities.
Applicant institutions, therefore, must also demonstrate a commitment and
sensitivity to preventive approaches that will address minority health.
 
For the purposes of the PCAA, the term preventive cardiology is used to define
the area of cardiovascular medicine having a special concern with the
development and the application of knowledge directed at the prevention of
heart and vascular diseases.  This includes the primary prevention of
cardiovascular diseases in infants, children, and adults who are at risk of
developing such diseases and the reduction of preventable complications or
disability in persons of all ages who have already developed cardiovascular
diseases.
 
DECA initiated the PCAA Program to provide a stimulus for development of a
preventive cardiology curriculum in those schools that do not have one and to
strengthen and improve the preventive cardiology curriculum in those schools
that do.  Awards provide support to individual faculty members for their
educational development and for implementation or expansion of the curriculum
in preventive cardiology.
 
Applications must be received by December 7, 1990, for review at the February,
1991 meeting of the National Heart, Lung, and Blood Advisory Council.  Awards
will be made with a July 1, 1991 start date.  The project period of the PCAA
must not exceed five years and each institution may receive the PCAA one time
only.  The number of new awards made will depend on the availability of funds.
This is a reissuance of the thirteenth and final announcement for the PCAA
program.

 
           NIH GUIDE - Vol. 19, No. 33, September 14, 1990 - Page 5
The PCAA program is intended to:
 
  o  encourage the development of a high-quality preventive cardiology
     curriculum in schools of medicine and osteopathy that will
     significantly increase the opportunities for minority students,
     house staff, and fellows to learn both the principles and practice
     of preventive cardiology;
 
  o  develop promising minority faculty whose interest and training are
     in preventive cardiology teaching, research, and practice;
 
  o  develop established faculty who have a major commitment to and
     possess educational skills for teaching preventive cardiology;
 
  o  facilitate interchange of educational ideas and methods applicable
     to teaching preventive cardiology among awardees and institutions;
     and
 
  o  develop at the grantee institution the ability to strengthen
     continuously the improved preventive cardiology curriculum, with
     local funds, subsequent to the award.
 
Requests for copies of the Preventive Cardiology Academic Award Program
Guidelines should be directed to:
 
Associate Director
Clinical Applications and Prevention Program
Division of Epidemiology and Clinical Applications
National Heart, Lung, and Blood Institute
Federal Building, Room 5C-01
Bethesda, MD  20892
Telephone:  (301) 496-1706 or 496-3503
 
This program of the NHLBI is identified in the Catalog of Federal Domestic
Assistance No. 13.837.  Awards will be made under the authority of the Public
Health Service Act, Section 301 (42 USC 241) and administered under PHS grant
policies and Federal Regulations, most specifically 42 CFR Part 52 and 45 CFR
Part 74.  This program is not subject to the intergovernmental review
requirements of Executive Order 12372 or to Health Systems Agency Review.

 

 

 

 

 

 

 

 

 

 

 

 

 
 
           NIH GUIDE - Vol. 19, No. 33, September 14, 1990 - Page 6